BDS Analytics’ June 2019 cannabis industry report reveals that medical marijuana sales in Arizona increased by 14% compared to June 2018.
The report discloses category-specific Arizona medical marijuana industry sales data, as NCV Newswire reported:
Sales for Arizona’s medical dispensaries were $56.6 million this past June, a four percent decrease from May, 2019. Compared to June, 2018, sales increased by 14 percent. Year-to-date sales increased by 13 percent compared the same period in 2018, reaching $333.6 million.
In June, the $24.1 million in sales of Flower contributed 43 percent of overall revenues for the month. Flower sales decreased by three percent from the trailing month and increased by 11 percent from the prior year. Year-to-date, Flower sales have increased four percent to $139.7 million.
The Concentrates product category contributed 39 percent of revenues in June. The $22 million in Concentrate sales represented an 18 percent increase compared to the prior June. In the first six months of 2019, Concentrate sales have increased 21 percent compared to the same period last year to $128.4 million. Concentrate sales are segmented into Dabbable and Vape products. Compared to the prior June, sales increased 13 and 20 percent for the two categories, respectively.
Sales of Ingestibles generated $7 million in sales in June 2019 and contributed 12 percent of total revenues for the month. Year-over-year sales for June increased by 20 percent. Year-to-date, the $44.1 million sold in Ingestibles was 27 percent greater compared to the same period in the prior year. The Ingestibles category includes both the Edible and Sublingual subcategories. Edibles contributed 84 percent of Ingestibles revenues in June and sales increased 18 percent compared to June, 2018. Sales of Sublinguals in June, 2019 have increased 33 percent compared to the same period last year.